Novel Advances in Modifying BMPR2 Signaling in PAH
Pulmonary Arterial Hypertension (PAH) is a disease of the pulmonary arteries, that is characterized by progressive narrowing of the pulmonary arterial lumen and increased pulmonary vascular resistance, ultimately leading to right ventricular dysfunction, heart failure and premature death. Current tr...
Main Authors: | Svenja Dannewitz Prosseda, Md Khadem Ali, Edda Spiekerkoetter |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/12/1/8 |
Similar Items
-
15 years journey of idiopathic pulmonary arterial hypertension with BMPR2 mutation
by: Kyung Jin Ahn, et al.
Published: (2019-10-01) -
BMP7 Signaling via BMPR1A, BMPR1B Inhibits the Proliferation of Lung Large Carcinoma NCI-H460 Cell
by: Huihui XU, et al.
Published: (2010-07-01) -
Identifying Potential Mutations Responsible for Cases of Pulmonary Arterial Hypertension
by: Egom EE, et al.
Published: (2021-03-01) -
PTPN1 Deficiency Modulates BMPR2 Signaling and Induces Endothelial Dysfunction in Pulmonary Arterial Hypertension
by: Md Khadem Ali, et al.
Published: (2023-01-01) -
Homozygous missense variant in BMPR1A resulting in BMPR signaling disruption and syndromic features
by: Bianca E. Russell, et al.
Published: (2019-11-01)